Results for pfizer biontech covid-19 vaccine week

Add to feed Create your own feed

Latest

Hong Kong set to approve Pfizer-BioNTech COVID-19 vaccine before end of week - SCMP

tweet picture

BREAKING: Canada's Pfizer-BioNTech COVID-19 vaccine shipment for next week deferred

tweet picture

The European Union, Canada and some other countries will receive fewer doses next week of the Covid-19 vaccine made by Pfizer and BioNTech due to an upgrade at Pfizer’s European factory

US bank indices have outperformed the wider market by more than 25 percentage points since Pfizer and BioNTech announced their Covid-19 vaccine success, gaining further support after Senate run-off races last week

tweet picture

A nurse in California has tested positive for COVID-19 a week after he was injected with the first shot of the Pfizer-BioNTech vaccine, as a medical expert said that it takes 10-14 days for the body to start developing protection provided by the vaccine.

European Union#EU ) officially begins its COVID-19 vaccination less than a week after the approval of Pfizer/BioNTech coronavirus vaccine and amid a rush to contain the spread of a new COVID-19 variant first detected in the UK.

tweet picture

Spain will receive 350,000 COVID-19 vaccine doses from Pfizer-BioNTech per week starting on Dec. 26, with a total of nearly 4.6 million to be delivered over the next 12 weeks, the country's health minister said.

Dubai will start inoculating people with the COVID-19 vaccine produced by Pfizer and BioNTech for free from Wednesday, the emirate’s government said, joining Saudi Arabia which last week became the first Arab country to begin using this vaccine

Approval of the Moderna COVID-19 vaccine means shots will start in Yukon 1st week of January, Yukon's health minister said. Remote & Indigenous communities across the North haven't seen doses of Pfizer-BioNTech vaccine because of its storage requirements.

The European Union drugs regulator has recommended authorizing the Pfizer/BioNTech Covid-19 vaccine for use, paving the way for the first phase of the bloc's mass vaccination program to begin later this week.

Loading
Loading

Most relevant

Europe’s medicines regulator approved the use of the COVID-19 vaccine developed by Pfizer and BioNTech, putting Europe on course to start inoculations within a week

tweet picture

Several states say they have been told to expect far fewer doses of the Pfizer-BioNTech COVID-19 vaccine in its second week of distribution. The Trump administration is downplaying the risk of delays, and Pfizer says its production levels have not changed.

BREAKING: The first Briton to get the Pfizer/BioNTech Covid-19 vaccine -- 90-year-old Margaret Keenan -- received the first of two doses at University Hospital in Coventry, less than a week after the UK became the first country to approve it.

BREAKING: The first Briton to get the Pfizer/BioNTech Covid-19 vaccine -- 90-year-old Margaret Keenan -- received the first of two doses at University Hospital in Coventry, less than a week after the UK became the first country to approve it.

📸: The first person in the world to receive the Pfizer/BioNTech COVID-19 vaccine outside a clinical trial was grandmother Margaret Keenan, who turns 91 next week.

tweet picture

UK authorises Pfizer-BioNTech COVID-19 vaccine, to be made available across the country from next week

tweet picture

JUST IN: The United Kingdom has approved the use of the Pfizer-BioNTech COVID-19 vaccine for use and roll out next week, the first country in the world to do so, Reuters reports. #COVID19 

tweet picture

BREAKING: United Kingdom becomes first country in the world to approve Pfizer/BioNTech Covid-19 vaccine. "The NHS stands ready to start vaccinating early next week," Health Sec. Hancock says.

BREAKING: The UK regulator has approved the Pfizer/BioNtech Covid-19 vaccine. We understand 40 million doses of the vaccine will be transported around the country within 8 hours. NHS staff could be vaccinated from next week. Watch GMB👉

JUST IN: Pfizer plans to apply for emergency use in the United States for its COVID-19 vaccine candidate being developed along with BioNTech as soon as a safety milestone is achieved in the third week of November

tweet picture

Loading
Loading